Clinical Trial Update: Reduced Exposure Study Using CHTP 1.0 During 5 Days in Confinement. [NA]

View source ↗

Summary

A completed clinical trial evaluating reduced exposure with CHTP 1.0 over 5 days in confinement for smoking.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Smoking

Drugs mentioned

• CHTP 1.0

Snippet

Sponsor: Philip Morris Products S.A. | Conditions: Smoking | NA | Status: COMPLETED | Results posted: 2017-03-10